GlobeNewswire Medical EquipmentQwen · 实盘不做把握 9/10不做原因:不是事件
北京时间·🕒 发布 04:05:00·⟳ 抓取 04:06:00·⚡ 决策 08-28 04:06:56 +56s·60.7 天前
ResMed宣布CEO和CFO将出席第24届摩根士丹利全球医疗大会
这是一条上市公司例行投资者关系公告——CEO和CFO将于9月15日出席摩根士丹利医疗大会。公告本身不包含任何新财务信息、业绩指引、产品进展、订单或监管变化。根据经验'megacap-soft-catalyst-materiality'，此类软催化不改变公司收入/利润/订单/供需约束，无法在可交易窗口内产生价格增量。Web/KB/行情查询均不可能改变这一判断，故经验门后早停。
📄 原文GlobeNewswire Medical Equipment↗ 原文
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and ch…
不做 ResMed（RMD.US）
会议出席预告无任何增量信息（无业绩指引、无产品、无订单、无监管变化），不构成可交易催化。事件方向中性，无edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
ResMed公告CEO/CFO将于9月15日出席摩根士丹利全球医疗大会，属于标准投资者关系活动预告，无新增财务、业务或监管信息。此类会议出席公告在历史上从不构成股价催化。事件方向中性，无增量事实，无可交易edge。
🔎 新鲜度:最早出现 2026-08-27 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无需先例即可判定不做
方向:不适用——会议出席公告不构成催化事件，无需先例定价
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- fetch_decision_experience 成功 stock_tools HTTP · 122 ms
{
原文全文
展开原文 · 1,447 字
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026. Resmed’s webcast presentation will begin at approximately 10:00 a.m. (Eastern Time).
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting
https://investor.resmed.com
. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors
For media
+1 858.221.3304
+1 619.510.1281
investorrelations@resmed.com
news@resmed.com
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting
https://investor.resmed.com
. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors
For media
+1 858.221.3304
+1 619.510.1281
investorrelations@resmed.com
news@resmed.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。